Curanex Pharmaceuticals Inc Proceeds from Issuance of Preferred Stock and Preference Stock
Curanex Pharmaceuticals Inc (CURX) reported Proceeds from Issuance of Preferred Stock and Preference Stock of $100 for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock · last filed 2026-03-30
- Curanex Pharmaceuticals Inc proceeds from issuance of preferred stock and preference stock for the quarter ending 2024-12-31 was $0.00.
- Curanex Pharmaceuticals Inc proceeds from issuance of preferred stock and preference stock for the quarter ending 2024-09-30 was $0.00.
- Curanex Pharmaceuticals Inc proceeds from issuance of preferred stock and preference stock for fiscal 2024 was $100.00.
| Period end | Proceeds from Issuance of Preferred Stock and Preference Stock 3 month | Proceeds from Issuance of Preferred Stock and Preference Stock 6 month | Proceeds from Issuance of Preferred Stock and Preference Stock 9 month | Proceeds from Issuance of Preferred Stock and Preference Stock 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $100.00 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $100.00 10-Q · filed 2025-11-17 | ||
| 2024-06-30 | $100.00 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |